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Abstract
Background: The flexibility of implantable neural probes has increased during the last 10 years, starting with stiff
materials such as silicone to more flexible materials like polyimide. We have developed a novel polymer based on
Off-Stoichiometry Thiol-Enes + Epoxy (OSTE+, consisting of a thiol, two allyls, an epoxy resin and two initiators), which is
up to 100 times more flexible than polyimide. Since a flexible neural probe should be more biocompatible than a stiff
probe, an OSTE+ probe should be more biocompatible than one composed of a more rigid material. We have
investigated the toxicity of OSTE+ as well as of OSTE+ that had been incubated in water for a week (OSTE+H2O)
using MTT assays with mouse L929 fibroblasts. We found that OSTE+ showed cytotoxicity, but OSTE+H2O did not.
Extracts were analyzed using LC-MS and GC-MS in order to identify leaked chemicals.
Results: Most constituents were found in extracts of OSTE+, whereas only initiators were found in OSTE+H2O
extracts. The detected levels of each chemical found in the LC-MS and the GC-MS analysis were below the
toxicity level when compared to MTT assays of all the individual chemicals, except for one of the initiators that
had an IC50 value close to the detected levels.
Conclusion: Our notion is that the toxicity of OSTE+ was caused by one of the initiators, by impurities in the
constituents or by synergistic effects of low doses of leaked chemicals. However, our conclusion is that if OSTE+ is
incubated for one week in water, OSTE+ is not cytotoxic and suitable for further in vivo studies.
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Background
The current research on neural probes for deep brain
stimulation has created new possibilities to treat condi-
tions such as chronic pain and motor symptoms associ-
ated with Parkinson’s disease, in addition to enabling
control of prosthetic limbs [1–4]. During the last couple
of years, the development of implantable neural probes
have been oriented towards flexible probes [5–14] made
out of polymers, instead of the previously stiff probes
made of silicon [15]. Since a more flexible probe will re-
duce the strain at the interface of the probe and the
tissue when compared to a more rigid probe, it should
also reduce the tissue response to the probe, thus a more
flexible neural probe should be more biocompatible then
a more rigid probe [13, 16]. Currently, the choice of ma-
terial for both insulation as well as for the backbone of
flexible intra-cortical neural probes has been Parylene C
or polyimide, and for flexible cortical neural probes:
either Parylene C, polyimide or polydimethylsiloxane
(PDMS). When comparing the flexibility according to
Young´s modulus, where a more rigid material has a
higher Young’s modulus value and a more flexible ma-
terial has a lower value (Table 1), PDMS is more flex-
ible than Parylene C and polyimide, even though all
three materials have significant stiffness as compared
to brain tissue. However, a technical drawback with PDMS
is the difficulty in patterning it using UV-lithography, and
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thus it has to be molded, impairing the possibility of pro-
ducing thin probes. In addition, a thin PDMS-based probe
would be so fragile that it would likely probably not be
possible to implant it into brain tissue.
Off-Stoichiometry Thiol-Enes + Epoxy (OSTE+) is a new
polymer that was developed to be used in microfluidic de-
vices [17] instead of PDMS, and we have then further de-
veloped it into a potential material for intra-cortical neural
probes [18]. The Young´s modulus of OSTE+ can be tuned
by shifting the ratio between the constituents and it can
easily be patterned using UV-lithography. We have devel-
oped a composition of OSTE+ that is as stiff as polyimide
at 10 °C, and roughly 100 times more flexible at a
physiological temperature, 37 °C (Table 1) [18]. In UV-
lithography, OSTE+ is a negative photoresist and can
be spin-coated into very thin layers where the thickness
of the layer can be controlled by the spin speed. An-
other advantage OSTE+ affords is that the fabrication
protocol is close to that of polyimide and it can there-
fore easily replace polyimide in current neural probes.
There are several studies showing the biocompatibility
of Parylene C, PDMS and polyimide [19–23]. However,
since OSTE+ is a new material, limited work has been
done in this area [24].
In this study, our goals were to determine the biocom-
patibility of OSTE+ as well as investigate if there was
leaching of constituents from the final polymer. The bio-
compatibility of various preparations of OSTE+ was tested
using in vitro cytotoxicity assays (MTT assays) together
with microscopy techniques and the analysis of possible
constituents leaching from the materials was performed
with liquid chromatography - mass spectroscopy (LC-MS)
and gas chromatography – mass spectroscopy (GC-MS).
This is an initial study of the cytotoxicity of OSTE+ and
the results show that OSTE+, if handled correctly, renders
low toxicity to cells, this warrants further studies in com-
pliance with ISO 10993–1 in order to completely deduce
the biocompatibility.
Methods
The manufacturing of the OSTE+ samples started with a
molding step where the samples were cured in a PDMS
mold using UV-light, followed by a post exposure bake
at 65 °C. Half of the OSTE+ samples were then incu-
bated in MilliQ water (Millipore, Bedford, MA, USA) at
room temperature for 7 days to allow non-bound constit-
uents to leach out. These samples are called OSTE+H2O
throughout this paper. All samples were then incubated in
water at 37 °C for 72 h (in compliance with ISO standard
10993–12) and the extractions were used in two different
assay systems: chemical analysis and cytotoxicity analysis
(in compliance with ISO standard 10993–5). The whole
process is shown schematically in Fig. 1.
The cytotoxicity tests were performed using MTT as-
says in compliance with ISO standard 10993–5, and all
samples were extracted using ISO standard 10993–12.
Polymer fabrication
OSTE+
OSTE+ is produced in a two-step polymerization reaction
as previously described [18]. First, a fast UV-initiated rad-
ical polymerization step results in a cross-linked network
of some of the thiol groups and of all the ene groups in
the allyls. Then a thermal anionic polymerization step re-
sults in a fully polymerized network with the unreacted
thiol groups and the epoxy resin.
In the first polymerization step, UV light was used o
activate Lucirin® TPO-L (BASF, Germany) that initi-
ated cross-linking between the thiol, tris[2-(3-mercap
Table 1 Young´s modulus values of brain tissue, Parylene C,
PDMS, polyimide and OSTE+ [12–15]
Material Young’s modulus
Brain tissue 0.5-1 kPa
Parylene C 4 GPa
PDMS 0.36–1.24 MPa
Polyimide 2.48 GPa
OSTE+ @ 10 °C 1.9 GPa
OSTE+ @ 37 °C 50 MPa
Fig. 1 A schematic representation of the procedure used in this study. A mixture of OSTE+ was shaped into blocks using a PDMS mold. The OSTE+
material was formed by a two-step polymerization process: first a UV-initiated step (exposure time of 40 min) followed by a heat-initiated step in which
the samples were placed in an oven at 65 °C overnight. Half of the samples were placed in water for a week, allowing eventual unreacted constituents
to leak out. Extractions were made by placing a sample of each material into a vial with water and the vial was then gently shaken at 37 °C for 72 h.
The extractions were then used in chemical analysis and biological assays
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topropionyloxy)ethyl] isocyanurate (90 %, Sigma Aldrich,
Germany), and the two allyls, trimethylolpropane diallyl
ether (90 %, Sigma Aldrich) and 2,4,6-triallyloxy-1,3,5-tria-
zine (97 %, Sigma Aldrich). In the second polymerization
step, 1,5-diazabicyclo[4.3.0]non-5-ene (98 %, DBN, Sigma
Aldrich) was used as the initiator for cross-linking be-
tween the thiol and the epoxy resin, D.E.N 341 Epoxy
Novolac resin (Dow Chemicals, USA).
All ingredients were weighed according to a stoichiomet-
ric ratio of monomers of 1.5 : 0.47 : 0.53 : 0.5 for thiol, dia-
llyl, triallyl and the epoxy resin, respectively. TPO-L and
DBN were used at 0.2 %. Finally, 3 % acetone (Sigma
Aldrich) was added to the mixture. All ingredients were
mixed and degassed under vacuum for 5 min. The mix-
ture was then poured into a pre-fabricated PDMS mold.
The mold containing the mixture was then covered
with a polycarbonate film and exposed to UV-light for
40 min using a Karl Suss MA4 mask aligner. The poly-
carbonate film was removed after the exposure and the
OSTE+ pieces were hard-baked (to finalize the thiol-epoxy
polymerization) in an oven at 65 °C overnight. The ratio of
the different constituents results in an OSTE+ with a glass
transition temperature of 39 °C [18].
Polyimide
Polyimide was selected as a reference material since it is a
material used in neural probes today [8, 9, 11, 13, 20, 22].
Polyimide (Durimide 7505, FujiFilm, Belgium) was poured
into a PDMS mold, followed by a 2 h soft-bake (to remove
the solvents) at 85 °C. The mold with polyimide was ex-
posed to UV-light for 40 min using a Karl Suss MA4 mask
aligner. The polyimide was then hard-baked (cured) in an
oven at 200 °C for 4 h. Finally, the polyimide pieces were
rinsed in MilliQ water.
HDPE
A sheet of HDPE (Bay Plastics LTD, England) was cut into
pieces using a milling machine. The pieces were cleaned
with acetone (Sigma Aldrich) in an ultrasonic bath followed
by a rinse in ethanol (Solveco, Sweden) and MilliQ water.
Polymer extraction
Extractions of polymer samples were obtained according
to ISO standard 10993–12. The extraction was performed
in cleaned borosilicate glass vials and water (LC-MS Ultra
Chromasolv, Sigma Aldrich, for the chemical analysis and
MilliQ water for the cytotoxicity analysis) was used as the
extraction medium. The ratio of the surface area of the
OSTE+, OSTE+H2O, polyimide or HDPE samples and the
water was 3 cm2/ml. The samples were washed in MilliQ
water before extraction. The vials were gently shaken at
37 °C for 72 h. When the extraction solution was used in
cytotoxicity tests, the polymer samples were first sterilized
using an autoclave at 121 °C and the extractions were per-
formed with sterile water.
Chemical analysis
LC-MS analysis
To obtain standards for the LC-MS analysis, an exact
amount of each chemical used for the production of
OSTE+ was dissolved in methanol (Sigma Aldrich) over-
night (except acetone and D.E.N 431). The following day
the solutions were diluted to a concentration of 500 μg/ml
using 50 % MilliQ water and 50 % methanol. This was
followed by a second dilution step to 50 μg/ml using
MilliQ water. Acetone was not tested since it is not de-
tectable in the LC-MS system used; D.E.N 431 was not
tested since it is not water-soluble. To simulate the
UV-lithography process of the fabrication of OSTE+, all
standards were exposed to UV-light using a Karl Suss
MA4 mask aligner for 40 min. All standards, extractions
(described above) of OSTE+, extractions of OSTE+H2O
as well as blank samples, were analyzed using LC-MS.
A LC-MS system (QStar XL, Sciex, together with an
Agilent 1100 LC system) was used with an Acquity CHS
C18 1.7 μm 2.1x50 mm column and a sample volume of
5 μl. The mass spectrometer was configured to scan
120–1000 Da at 2 scans/s. Acetonitrile (LC-MS, Chro-
masolv, Sigma Aldrich) and MilliQ water were used at
a flow rate of 250 μl/min. The concentration of aceto-
nitrile in the mobile phase was: starting at 5 % for 1 min,
ramp to 95 % over 3 min, hold for 2 min, ramp down to
5 % in 0.1 min.
GC-MS analysis
To obtain standards for the GC-MS analysis, an exact
amount of all constituents (except acetone) was dissolved
in toluene (Sigma Aldrich and VWR). To simulate the
UV-lithography process of the fabrication of OSTE+, all
samples were exposed to UV-light for 40 min using a Karl
Suss MA4 mask aligner. 400 μl of the OSTE+ extractions
or OSTE+H2O extractions (described above) was pipetted
to a new vial containing 1 ml of toluene. The toluene ex-
traction samples were mixed using a vortex for 40 h,
followed by centrifugation for 1 min. To ensure that all
chemicals in the extracts were transferred into the organic
phase, 2 samples of each extraction were made acidic by
adding 50 μl of 0.1 M HCl (VWR) and 2 samples of each
extraction were made basic by adding 50 μl of 0.1 M
NaOH (VWR) just before the addition of toluene to each
extraction. The extracts spiked with HCl are referred to as
OSTE+/HCl and OSTE+H2O/HCl throughout the paper
and the extracts spiked with NaOH are referred to as
OSTE+/NaOH and OSTE+H2O/NaOH throughout the
paper. All samples and extracts together with a sample of
pure toluene were analyzed using GC-MS. Acetone was
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not tested since it is used as a cleaning step in the GC-MS
analysis.
All analyses were performed on a gas chromatograph
(Agilent 6890) equipped with an injector in split mode at
250 °C, equipped with an auto sampler (sample volume of
5 μl) and a mass spectrometry detector (Agilent 5973-N).
The column used in the system was a HP-5 ms fused silica
capillary column (5 % phenyl-methylpolysiloxane) of
30 m × 0.25 mm with a phase thickness of 0.25 μm.
The temperature program of the column was: 50 °C,
hold for 1 min, ramp to 300 °C over 10 min, hold for
15 min. The carrier gas used was helium at a flow rate
of 1.2 ml/min. The mass spectrometer was run in either
scan mode (30–600 Da with 2.6 scan/s) or in selected ion
monitoring (SIM) mode, using mass to charge ratios (m/z)
of 70, 81, 82, 99, 123, 125, 147, 187, 197, 254, 321 together
with a dwell time of 20 ms.
Scanning electron microscopy analysis of OSTE+
Four OSTE+ pieces were cut into two halves. One half
was put into MilliQ water for 7 days and then each pair
was studied by scanning electron microscopy (SEM, SU
8010, Hitachi, Japan) to see if 7 days of incubation in
water affected the surface of OSTE+.
Cytotoxicity analysis
Four different materials were tested in the MTT assay:
OSTE+, OSTE+H2O, polyimide and HDPE. Polyimide
was selected since it is regarded as biocompatible and
there are several studies that can be used for compari-
son. HDPE is a biocompatible material that sometimes is
used as a negative control in different cell viability assays
[22, 25, 26].
Cell culture
The mouse fibroblast cell line L929 was purchased from
American Type Culture Collection (ATCC, LGC stan-
dards AB, Borås, Sweden) and was grown as a monolayer
culture in complete cell culture medium, i.e. RPMI-1640
medium supplemented with 10 % fetal bovine serum
(FBS), 100 U/ml penicillin, 100 μg/ml streptomycin and
1 mmol/l L-glutamine, at 37 °C in 5 % CO2 in air. The
cells were sub-cultured twice every week at a density of 12
500 cells/cm2.
Polymer extractions for cell culture
The extracts were obtained as described above and kept
at 4 °C for a maximum time of 24 h before use in the cyto-
toxicity assay with L929 cells. The extracts were diluted 1:2
in 2x concentrated RPMI-1640 medium supplemented with
20 % FBS, 200 U/ml penicillin, 200 μg/ml streptomycin and
2 mmol/l L-glutamine, i.e. a final extract concentration of
50 % in 1x concentrated RPMI-1640 containing 10 %
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin and
1 mmol/l L-glutamine, before addition to cell cultures
Further dilutions of the 50 % concentrated polymer extracts
were done in 1x concentrated RPMI-1640 medium supple-
mented with 10 % FBS, 100 U/ml penicillin, 100 μg/ml
streptomycin and 1 mmol/l L-glutamine.
MTT assay – extract testing
L929 cells were seeded in complete cell culture medium
in 96-well plates (2000 cells/well in 180 μl medium) and
were then incubated at 37 °C in 5 % CO2 in humidified
air for 24 h. The medium was then removed and chan-
ged to medium containing the different extracts at con-
centrations ranging from 6.25–50 % medium containing
2.5 % dimethyl sulfoxide (DMSO: positive control) or
control medium (complete cell culture medium with 0 %
extract). The cells were then kept at 37 °C in 5 % CO2 in
humidified air for 72 h before addition of MTT to a final
concentration of 0.5 mg/ml. The 96-well plates were in-
cubated with MTT at 37 °C for 1 h before removal of
the medium, and the cells with blue formazan crystals
were then dissolved in DMSO. The following spectrom-
etry reading at 540 nm was done using a SPECTRAmax
M2 instrument (Molecular Devices, Sunnyvale, CA,
USA) and analyzed using SoftMax® Pro v. 4.6 (Molecular
Devices). A number of 3–6 biological replicates (i.e. the
testing of independent extracts of OSTE+, OSTE+H2O,
polyimide and HDPE) were used for all the treatments
of the L929 cells and a number of 6 technical replicates
(i.e. number of n) from each extract were used for each
biological replicate. After correcting all absorbance values
for background, the percent of control was calculated as
absorbance units in the presence of test compound as per-
centage of that in control. The results of the MTT assay
are resumed to reflect the cell number, thus, 50 % percent
MTT reduction of control implies that there were 50 %
less cells at that treatment concentration [27].
MTT assay - individual chemicals
Each chemical used in the fabrication (except acetone), 1
or 0.1 mg, was added to a sterile flask and 1000 μl sterile
water was added. Further dilutions were made using sterile
water. D.E.N 431 was not soluble in water and after shak-
ing the sample and letting it stand for a while, only the
water solution was used in the test. L929 cells were seeded
in complete medium in 96-well plates (2000–3000
cells/well in 180 μl medium) and the plates were incu-
bated in a CO2 incubator for 24 h before addition of
the chemicals. Indicated concentrations of the chemi-
cals were added to the wells and the cells were incu-
bated for 72 h at 37 °C in 5 % CO2 in humidified air.
The dose response was evaluated using MTT as de-
scribed above.
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Phase contrast and fluorescence microscopy
L929 cells were seeded in 12-well plates containing ster-
ile glass coverslips, whereupon they were incubated at
37 °C in 5 % CO2 in humidified air for 24 h. The growth
medium was then removed and changed to growth
medium without extract or containing the different poly-
mer extracts (at a concentration of 50 %, obtained as de-
scribed above). The cells were then incubated for 72 h
before they were photographed with an Olympus CKX41
inverted phase contrast microscope (Olympus Corpor-
ation, Tokyo, Japan) equipped with an Olympus SC30
camera (Olympus Corporation) then analyzed using the
software cellSense Standard version 1.4 (Olympus Corpor-
ation). The cells were then fixed in 3.7 % paraformalde-
hyde for 15 min and washed with phosphate-buffered
saline (PBS). The fixed cells were stained with Alexa Fluor
647-conjugated phalloidin in PBS containing 1 % bovine
serum albumin and 1 % Tween-20 for 1 h and in PBS con-
taining 1 μg/ml bisbenzimide for 1.5 min to visualize the
cytoskeleton and nuclei, respectively. The glass coverslips
were mounted on glass slides using Mowiol 4–88 and left
in a refrigerator overnight. The samples were imaged with
a LSM510 confocal laser scanning microscope (Carl Zeiss
Microscopy GmbH, Oberkochen, Germany) equipped
with a Hamamatsu R6357 photomultiplier (Hamamatsu
Photonics K.K., Hamamatsu, Japan). A 405 nm diode-
pumped solid-state laser was used to excite the bisben-
zimide and a band-pass filter of 420–480 nm was used
for the emission. The Alexa Fluor 647-conjugated phal-
loidin was excited with a 633 nm HeNe ion laser and a
650 nm long-pass filter was used for the emission. The
cells were visualized by z-stacks composed of single op-
tical planes in high magnification and the images were
analyzed with the software ZEN 2012 (black edition)
version 8.0 (Carl Zeiss Microscopy GmbH).
Results
Chemical analysis using LC-MS
Standards of all constituents (except acetone and D.E.N
431), extracts of OSTE+, extracts of OSTE+H2O and
blank samples were analyzed using LC-MS.
From the total ion current (TIC) chromatogram together
with the molecular structure of each chemical and the
mass to charge ratio the lower limit of detection (LOD) for
each chemical could be calculated as well as the detection
level for each chemical in the samples (Table 2). The LOD
was calculated using a 3:1 ratio between signal/noise. As-
suming that Beer Lambert’s law was fulfilled, there should
be a linear relationship between the recorded signal and
the concentration. Then it was possible to calculate the de-
tected concentration using a single-point calibration curve




where C is the detected concentration, Cref is the con-
centration of the standard, href is the peak height of the
standard in the TIC and h is the peak height detected in
the sample for that specific mass to charge ratio that
corresponds to the chemical in question.
TIC chromatograms from the LC-MS analysis of OSTE+
extracts, OSTE+H2O extracts and blank samples are shown
in Fig. 2. Traces of all chemicals except trithiol were found
in the OSTE+ extracts, while in the OSTE+H2O extracts
only DBN and TPO-L were detected. It should be noted
that each peak shown in Fig. 2 contains several different
chemicals that contribute to the total height of the peak;
hence the peak labeled “Diallyl” contains several different
chemicals and diallyl is only a contributor in OSTE+, and is
not found in OSTE+H2O. Unidentified contributors to the
peak heights imply that there were impurities in the chemi-
cals or that they are derived from the chromatographic set
up. When comparing the peak height of all the different
chemicals in the OSTE+ and OSTE+H2O extractions, the
detected levels of each chemical are either lower or below
LOD for OSTE+H2O. Acetone and D.E.N 431 were not an-
alyzed since they are not water-soluble and standard curves
could not be made.
Chemical analysis using GC-MS
Standards of all constituents, extracts of OSTE+, extracts
of OSTE+H2O and blank samples were analyzed using
Table 2 Corresponding mass to charge ratio, LOD and detected level for each constituent found using LC-MS
Constituent m/z LOD (μg/ml) Detected level in OSTE+ extracts (μg/ml) Detected level in OSTE+H2O extracts (μg/ml)
DBN 125 2.0 37.0 31.6
D.E.N 431 163, 325–327, 488-491 n,d.1 n,d. n,d.
Diallyl 215 2.0 2.4 b,d,l,2
TPO-L 121, 147, 317 1.2 2.4 1.4
Triallyl 250 1.7 2.4 b,d,l.
Trithiol 524 0.7 b,d,l. b,d,l.
1n,d. not determined
2b,d,l. below detection limit
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GC-MS. The standards were analyzed using the GC-MS
in scan mode. Peaks and different mass to charge ratios
for all chemicals were obtained from this analysis. In order
to increase the sensitivity of the GC-MS, all mass to
charge ratios found when running the GC-MS in scan
mode were used to run the GC-MS in SIM mode. Ana-
lysis of data from running the GC-MS in SIM mode
allowed for the calculation of the lower limit of detec-
tion of all chemicals (see Table 3) in the same way as
described for the LC-MS.
All extracts of OSTE+, OSTE+H2O, OSTE+/HCl,
OSTE+/NaOH, OSTE+H2O/HCl, OSTE+H2O/NaOH
and all blank samples were run through the GC-MS both
in SCAN mode and in SIM mode. No detectable traces of
the constituents were found in any of the extracts.
SEM analysis
SEM images of OSTE+ and OSTE+H2O samples are
shown in Fig. 3. Visible inspection revealed that the nano-
sized cracks are slightly bigger in the OSTE+H2O than in
the OSTE+ sample.
Cytotoxicity
To evaluate the cytotoxicity of the OSTE+ and OSTE
+H2O extracts in vitro, the mouse fibroblast cell line
L929 was used in MTT assays. Extracts from HDPE and
polyimide were used a negative controls and references
samples, respectively, and 2.5 % DMSO was used as a posi-
tive control (Fig. 4a). The L929 cells were treated with con-
centrations ranging from 6.25–50 %, of the different
polymer extracts for a total time of 72 h. The data was ana-
lyzed using a 2-way ANOVA, comparing the data for each
set vs. control and the results show a statistically significant
and concentration-dependent decrease in MTT reduction
in cells treated with OSTE+ extracts, compared to control
cells (Fig. 4a). When diluted to 50 %, the OSTE+ extract
lowered the MTT reduction about 40 % compared to con-
trol implying that there were 40 % fewer cells compared to
control since MTT reduction is assumed to reflect the
number of viable cells. At a 25 % dilution, the MTT re-
duction was lowered about 15 % compared to control.
The same indications of toxicity seen after treatment
with OSTE+ extracts were not found after treatment
with OSTE+H2O, polyimide or HDPE extracts (Fig. 4a).
Additionally, to investigate effects on cell morphology,
cells treated with the different polymer extracts (50 %)
were studied using phase contrast and confocal micros-
copy. The cells photographed in the phase contrast micro-
scope were non-stained and non-fixed (i.e. viable) whereas
the cells photographed in the confocal microscope were
fixed and stained with phalloidin and bisbenzimide to
visualize the cytoskeleton (actin filaments) and the nuclei,
respectively (Fig. 4c). No changes in morphology could be
seen in cells treated with the polymer extracts for 72 h,
compared to control. Thus, the OSTE+ toxicity found in
the MTTassay did not result in a morphological change.
To further study the toxicity of OSTE+ and to evaluate
the difference in toxicity between OSTE+ and OSTE+H2O,
the individual chemicals used to produce OSTE+ were
tested in MTT assays. As seen in Fig. 4b, DBN, diallyl,
Fig. 2 Mean TIC chromatograms from LC-MS: red is OSTE+, black is OSTE+H2O and the blue is the blank sample, n = 2. Analysis shows that one
peak mainly contains DBN, two peaks that contain TPO-L and one peak contains some diallyl
Table 3 LOD of GC-MS (SIM mode)
Constituent LOD of GC-MS
DBN 1.6 μg/ml
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Fig. 3 Scanning electron microscopy images of OSTE+ and OSTE+H2O. Scale bar = 1 μm
Fig. 4 a Results from MTT assay tests using the L929 cell line. The L929 cells were seeded and allowed to attach in the wells of 96-well plates for
24 h. The cells were then subjected to extraction solutions of OSTE+, OSTE+H2O, polyimide and HDPE for 72 h at different concentrations (6 %,
12.5 %, 25 % and 50 %). DMSO at 2.5 % was used as a positive control. The results are presented as mean values (n = 18–36) and the error bars
represent ± SEM. The data was analyzed using a 2-way ANOVA, comparing the data for each set vs. control where ** represents a P-value≤ 0.01
and **** represents a P-value≤ 0.0001. b The L929 cells were seeded and after 24 h treated for 72 h with the chemicals that were used in the
production of OSTE+. Cell viability was assessed using the MTT assay. The results are presented as mean values (n= 6–18) and the bars represent ± SEM.
All chemicals, used as single agents, are non-toxic at concentrations below 1 μg/ml. c Phase contrast (top row) and confocal microscopy (bottom row)
images of mouse L929 cells exposed to extracts of OSTE+, OSTE+H2O, polyimide and HDPE at a 50 % concentration for 72 h. The phase contrast images
show viable and non-stained cells whereas the cells visualized with confocal microscopy were fixed and stained to show the actin cytoskeleton (red) and
the nuclei (blue). The scale bars are equal to 50 μm. Images shown were taken in areas with similar cell densities
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trithiol and triallyl had effects on cell viability at con-
centrations above 1 μg/ml. IC50 values for all constitu-
ents were obtained using linear regression in the area
around the 50 % MTT reduction (EXCEL, Table 4) and
compared to the levels found when using LC-MS modi-
fied to represent extracts diluted to 50 %, i.e. the re-
ported levels from Table 2 were divided by 2. DBN was
the only chemical were the detected level was close to
the IC50 level.
Discussion
OSTE+ is a new polymer that is more flexible then other
polymers used for neural probes. This should allow probes
constructed in OSTE+ to follow the micro motions of the
brain, hence increasing the biocompatibility of the neural
probe [16]. Our group has previously shown that it is pos-
sible to make implantable neural probes in OSTE+ [18].
However there is one important question: is OSTE+ bio-
compatible? In our study we decided to give an answer to
this question by using standardized biocompatibility tox-
icity tests used by the industry. Cytotoxicity was investi-
gated using MTT assays with L929 cells in compliance
with ISO standard 10993–5. The MTT assay was used to
investigate the cytotoxicity of extracts of four different
materials (OSTE+, OSTE+H2O, polyimide and HDPE)
and of the individual chemicals that were used in the
OSTE+ fabrication process. The morphology of cells
treated with extracts was investigated using phase contrast
and confocal microscopy. GC-MC and LC-MS were used
to analyze chemicals found in extracts of OSTE+ and ex-
tracts of OSTE+H2O. SEM was used to investigate the
surface structure of OSTE+ and OSTE+H2O.
The results of the cytotoxicity test (Fig. 4a) imply that
OSTE+ used directly after production may be toxic if
not washed properly before implantation. The reduction
of MTT is assumed to be proportional to cell number
and thus at the highest concentration (extract diluted
50 %), the OSTE+ extract significantly reduced the cell
number thus implying an effect on cell proliferation. Using
confocal microscopy and phase contrast microscopy we
could not find any morphological changes imposed by any
of the treatments (Fig. 4c). We cannot, however, exclude
the possibility that higher magnification microscopy or the
use of other cellular staining probes than phalloidin stain-
ing of actin may indicate morphological changes. To be
able to draw conclusions about the exact mechanism of
toxicity, more elaborate investigations have to be made.
On the other hand, that may not be warranted since
the toxicity disappeared when the OSTE+ samples were
pre-incubated in water as an extra washing step.
The chemical analysis (LC-MS) showed that the water-
soluble chemicals DBN, diallyl, triallyl and TPO-L were
found in the extracts made from OSTE+. But only DBN
and TPO-L were detected in the OSTE+H2O extracts,
which is expected since they are only used as initiators in
the process and are not immobilized in the final polymer
network. Because the detected levels of most constituents
were close to the respective LOD, some may still have
leached out into the OSTE+H2O extracts. The IC50 value
found for DBN (Table 4) is close to the detected levels of
DBN in extracts of OSTE+ and in extracts of OSTE+H2O,
and as seen in Fig. 4b the steep curve for DBN could ex-
plain the difference in toxicity between the extracts OSTE+
and the extracts of OSTE+H2O. Comparing the IC50
values for diallyl and triallyl in the OSTE+ extracts with
the detected levels (Table 4) the IC50 values are six times
greater for diallyl and 60 times greater for triallyl. Hence,
our conclusion is that neither diallyl nor triallyl are respon-
sible for the toxicity found in the OSTE+ extracts. The lack
of results from the extracts analyzed using the GC-MS is
probably because most of the constituents are water sol-
uble and thus were not extracted into the toluene phase
from the water phase. Since acetone was used in the fabri-
cation process, it is a possible candidate for toxicity. How-
ever, acetone was used as a 3 % concentration in the
fabrication mixture which was then degassed, exposed
to UV-light and baked at 65 °C over night. Since acet-
one is a highly volatile substance, the concentration was
likely lowered substantially. Remaining acetone may of
course have leaked into the extract but a hypothetical
calculation of concentration in the extract with no evapor-
ation during the production process would give at hand a
Table 4 IC50 values obtained from the dose response curves shown in Fig. 4b and levels detected in the LC-MS analysis modified to
represent extracts diluted to 50 %
Constituent IC50 (μg/ml) 50 % OSTE+ extracts (μg/ml) 50 % OSTE+H2O extracts (μg/ml)
DBN 23,1 18.5 15.8
D.E.N 431 >100 n,d.1 n,d.
Diallyl 6.8 1.2 b,d,l.2
TPO-L >100 1.2 0.7
Triallyl 61.3 1.2 b,d,l.
Trithiol 7.9 b,d,l. b,d,l.
1n,d. not determined
2b,d,l. below detection limit
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maximum concentration in the medium of 0.2 % which
is below a concentration that has shown toxicity in cells
[30, 31]. Thus, we do not think acetone contributed to
toxicity of OSTE+. The unidentified peaks in the LC-MS
spectra (Fig. 2) support the existence of impurities, but
since we were unable to identify the peaks their role in the
toxicity cannot be determined. Neither have we tested
possible synergistic effects of the low doses of the leaked
compounds. Since we did not autoclave the samples used
in the chemical testing, there could be a small variation
between the extracts used in the MTT assays and in the
chemical testing. However, the variation should be insig-
nificant since the state of the material does not change
when increasing the temperature above the temperature
used in the hard-baking step.
Since oxygen will inhibit the UV-initiated polymerization
step and PDMS has a high oxygen permeability [32, 33],
the use of a spin-casting technique instead of PDMS molds
should allow for a better polymerization of OSTE+ and de-
crease the amount of unreacted constituents in the final
polymer. The surface analysis, using SEM (Fig. 3) shows
that there was a small difference between OSTE+ and
OSTE+H2O samples. The nano-sized cracks were some-
what wider in the OSTE+H2O sample. In our previous
work we did not use acetone in the mixture and we did
not see any cracks when using that formula [18]. We
therefore hypothesize that these cracks appeared dur-
ing a fabrication step where acetone evaporated. Since
acetone was added in order to make the mixture less
viscous and easier to use in a mold, the use of spin casting
should allow for a fabrication protocol without the use of
acetone, which hopefully will prevent the formation of
nano-sized cracks.
Conclusion
OSTE+ is a very promising material to use for neural
probes because of its superior flexibility compared to
other polymers used in neural probes today. The toxicity
of OSTE+ extracts was presumably derived from DBN,
unknown impurities in the constituents or from low dose
synergetic effects of the constituents. However, by pre-
incubating the final polymer in water for 7 days, OSTE+
was shown to be nontoxic to cells. The use of high-purity
chemicals in the fabrication process, removal of acetone
from the fabrication, the addition of a cleaning step in
water during fabrication and the use of a silicon wafer as
the substrate instead of PDMS should minimize the tox-
icity rendering implants made from OSTE+ nontoxic. In
order to ensure the biocompatibility of OSTE+ for neural
implants both short and long term in vivo tests have to be
conducted.
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